“COST-EFFECTIVENESS ANALYSIS OF PEMBROLIZUMAB IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW” (2026) Vietnam Journal of Community Medicine, 67(10). doi:10.52163/yhc.v67i10.6921.